Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IBTX
2976
DELISTED
Independent Bank Group, Inc.
IBTX
| $1.99M | ﹤0.01% |
35,820
+12,081
| +51% | +$671K |
|
|
DRNA
2977
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.98M | ﹤0.01% |
89,995
+59,544
| +196% | +$1.2M |
|
2978
City Holding Co
CHCO
$2.04B
| $1.98M | ﹤0.01% |
24,189
+2,621
| +12% | +$208K |
|
|
WIRE
2979
DELISTED
Encore Wire Corp
WIRE
| $1.98M | ﹤0.01% |
34,523
+5,293
| +18% | +$304K |
|
2980
McGrath RentCorp
MGRC
$2.92B
| $1.98M | ﹤0.01% |
25,870
+11,996
| +86% | +$871K |
|
2981
CALL
Signet Jewelers
SIG
$3.76B
| $1.98M | ﹤0.01% |
91,100
+12,500
| +16% | +$222K |
|
2982
CALL
Parker-Hannifin
PH
$135B
| $1.98M | ﹤0.01% |
9,600
-5,400
| -36% | -$1.05M |
|
2983
NCR Voyix
VYX
$1.14B
| $1.97M | ﹤0.01% |
91,459
-97,390
| -52% | -$1.9M |
|
|
DENN
2984
DELISTED
Denny's
DENN
| $1.97M | ﹤0.01% |
99,154
-3,943
| -4% | -$81.2K |
|
2985
CALL
Raymond James Financial
RJF
$34B
| $1.97M | ﹤0.01% |
33,000
-13,200
| -29% | -$762K |
|
2986
CALL
Scorpio Tankers
STNG
$3.81B
| $1.97M | ﹤0.01% |
+50,000
| New | +$1.71M |
|
|
BRKL
2987
DELISTED
Brookline Bancorp
BRKL
| $1.97M | ﹤0.01% |
119,404
+24,865
| +26% | +$392K |
|
2988
PUT
British American Tobacco
BTI
$128B
| $1.97M | ﹤0.01% |
46,300
+8,900
| +24% | +$335K |
|
2989
PUT
Yum! Brands
YUM
$41.1B
| $1.96M | ﹤0.01% |
19,500
+12,800
| +191% | +$1.33M |
|
2990
Tactile Systems Technology
TCMD
$665M
| $1.96M | ﹤0.01% |
29,077
+6,314
| +28% | +$349K |
|
|
SGMO
2991
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.96M | ﹤0.01% |
234,472
+19,540
| +9% | +$180K |
|
2992
Workiva
WK
$3.54B
| $1.96M | ﹤0.01% |
46,586
+15,069
| +48% | +$635K |
|
2993
Kodiak Sciences
KOD
$2.84B
| $1.96M | ﹤0.01% |
27,212
+10,634
| +64% | +$387K |
|
2994
CALL
Direxion Daily Technology Bull 3x ETF
TECL
$6.21B
| $1.96M | ﹤0.01% |
81,000
| – | – |
|
2995
CALL
Abercrombie & Fitch
ANF
$5B
| $1.96M | ﹤0.01% |
113,100
+84,700
| +298% | +$1.4M |
|
|
SMAR
2996
DELISTED
Smartsheet Inc.
SMAR
| $1.96M | ﹤0.01% |
43,517
-29,166
| -40% | -$1.21M |
|
|
DCPH
2997
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.96M | ﹤0.01% |
31,408
-2,140
| -6% | -$102K |
|
2998
Central Garden & Pet Co Class A
CENTA
$2.44B
| $1.95M | ﹤0.01% |
83,171
+26,133
| +46% | +$587K |
|
2999
PUT
SBA Communications
SBAC
$19.5B
| $1.95M | ﹤0.01% |
8,100
+7,900
| +3,950% | +$1.87M |
|
3000
PUT
iShares US Home Construction ETF
ITB
$2.35B
| $1.95M | ﹤0.01% |
43,900
-55,000
| -56% | -$2.45M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.